Fluvoxamine Long COVID Fatigue: McMaster Study | AcademicJobs
McMaster University researchers lead trial showing fluvoxamine reduces long COVID fatigue, highlighting Canada's higher ed role in global health innovation.
No reviews yet. Be the first to rate Edward!
Edward Joseph Mills is a part-time professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University. He holds a PhD from McMaster University, an MSc from Oxford University, and an MSt from Oxford University. Mills is a Fellow of the Royal College of Physicians of Edinburgh, a Fellow of the Royal College of Physicians of London, and a Fellow of the Royal College of Physicians of Ireland.
Mills has led and contributed to major clinical trials, including the TOGETHER trial, which evaluated treatments for COVID-19 such as fluvoxamine and ivermectin. His work has focused on evidence-based approaches to infectious diseases and platform trial infrastructure. He has authored hundreds of publications with extensive citations in the field of medicine. Mills has also been involved in research on long COVID and other health interventions, serving as senior author on studies examining treatments like fluvoxamine for fatigue associated with the condition.
McMaster University researchers lead trial showing fluvoxamine reduces long COVID fatigue, highlighting Canada's higher ed role in global health innovation.